Mirador Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,661
| Closed | -$308K | – | 210 |
|
|
2023
Q3 | $308K | Buy |
2,661
+1
| +0% | +$116 | 0.07% | 147 |
|
|
2023
Q2 | $274K | Hold |
2,660
| – | – | 0.06% | 163 |
|
|
2023
Q1 | $290K | Sell |
2,660
-200
| -7% | -$21.8K | 0.07% | 153 |
|
|
2022
Q4 | $325K | Buy |
+2,860
| New | +$325K | 0.08% | 146 |
|
|
2022
Q3 | – | Sell |
-2,885
| Closed | -$230K | – | 204 |
|
|
2022
Q2 | $230K | Sell |
2,885
-50
| -2% | -$3.99K | 0.05% | 171 |
|
|
2022
Q1 | $309K | Sell |
2,935
-50
| -2% | -$5.26K | 0.06% | 175 |
|
|
2021
Q4 | $322K | Sell |
2,985
-577
| -16% | -$62.2K | 0.07% | 181 |
|
|
2021
Q3 | $390K | Buy |
3,562
+27
| +0.8% | +$2.96K | 0.09% | 162 |
|
|
2021
Q2 | $331K | Buy |
3,535
+60
| +2% | +$5.62K | 0.07% | 170 |
|
|
2021
Q1 | $320K | Sell |
3,475
-15
| -0.4% | -$1.38K | 0.08% | 145 |
|
|
2020
Q4 | $255K | Hold |
3,490
| – | – | 0.07% | 155 |
|
|
2020
Q3 | $271K | Sell |
3,490
-110
| -3% | -$8.54K | 0.08% | 146 |
|
|
2020
Q2 | $200K | Buy |
+3,600
| New | +$200K | 0.07% | 151 |
|
|
2020
Q1 | – | Sell |
-16,455
| Closed | -$596K | – | 187 |
|
|
2019
Q4 | $596K | Buy |
+16,455
| New | +$596K | 0.24% | 92 |
|